Early clinical assessment of glucose metabolism in renal allograft recipients: Diagnosis and prediction of post-transplant diabetes mellitus (PTDM)

Nephrology Dialysis Transplantation

Volumn 23, Issue 6, 2008, Pages 2033-2042

  Kuypers, Dirk R J ^a   Claes, Kathleen ^a   Bammens, Bert ^a   Evenepoel, Pieter ^a   Vanrenterghem, Yves ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Immunosuppressive drugs; New onset diabetes mellitus after transplantation (NODAT); Oral glucose tolerance test (OGTT); Post transplant diabetes mellitus (PTDM); Renal transplantation

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BASILIXIMAB; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DACLIZUMAB; FINGOLIMOD; GLICLAZIDE; GLIQUIDONE; GLUCOCORTICOID; GLUCOSE; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THIAZIDE DIURETIC AGENT; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; DIABETES MELLITUS; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UNIVARIATE ANALYSIS;

BLOOD GLUCOSE; DIABETES MELLITUS; EARLY DIAGNOSIS; EVALUATION STUDIES AS TOPIC; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 44449121864     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm875     Document Type: Article

References (29)

1. Davidson J, Wilkinson A, Dantal J et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation 2003; 75: SS3-SS24
2. Kasiske BL, Snyder JJ, Gilbertson D et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185
3. Davidson JA, Wilkinson A. New-onset diabetes after transplantation 2003 international consensus guidelines: an endocrinologist's view. Diabetes Care 2004; 27: 805-812
4. Montori VM, Basu A, Erwin PJ et al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002; 25: 583-592
5. Roth D, Milgrom M, Esquenazi V et al. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation 1989; 47: 278-281
6. Cosio FG, Pesavento TE, Kim S et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440-1446
7. Jindal Rm, Hjelmesaeth J. Impact and management of posttransplant diabetes mellitus. Transplantation 2000; 70: S58-S63
8. Revanur VK, Jardine AG, Kingsmore DB et al. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001; 15: 89-94
9. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000; 11: 1735-1743
10. Woodward RS, Schnitzler MA, Baty J et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003; 3: 590-598
11. Markell M. New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis 2004; 43: 953-965
12. Benhamou PY, Penfornis A. Natural history, prognosis and management of transplantation-induced diabetes mellitus. Diabetes Metab 2002; 28: 166-175
13. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: S5-S20
14. Racusen L, Colvin RB, Solez K et al. Antibody-mediated rejection criteria-an addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714
15. Cockcroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
16. Vesco L, Busson, M, Bedrossian J et al. Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors. Transplantation 1996; 61: 2465-2466
17. van Hooff JP, Christiaans MH, van Duijnhoven EM. Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005; 79: 1465-1469
18. Shah T, KasraviA,HuangEet al.Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 2006; 82: 1673-1676
19. Joss N, Staatz CE, Thomson AH et al. Predictors of new onset diabetes after renal transplantation. Clin Transplant 2007; 21: 136-143
20. Rodrigo E, Fernandez-Fresnedo G, Valero R et al. New-onset diabetes after kidney transplantation: risk factors. J Am Soc Nephrol 2006; 17: S291-S295
21. van Hooff JP, Christiaans MH, van Duijnhoven EM. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant 2004; 19: vi8-vi12
22. Sharif A, Moore RH, Baboolal K. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: an under diagnosed phenomenon. Transplantation 2006; 82: 1667-1672
23. Hamer RA, Chow CL,Ong AC et al. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007; 83: 36-40
24. Halimi JM, Laouad I, Buchler M et al. Early low-grade proteinuria: causes, short-term evolution, and long-term consequences in renal transplantation. Am J Transplant 2005; 5: 2281-2288
25. Vincenti F, Friman S, Scheuermann E et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506-114
26. van Duijnhoven EM, Christiaans MH, Boots JM et al. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. J Am Soc Nephrol 2002; 13: 213-220
27. Abramowicz D, Vanrenterghem Y, Squifflet JP et al. Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial. Clin Transplant 2005; 19: 475-482
28. Rodrigo E, Pinera C, de Cos MA et al. Evolution of tacrolimus blood levels and concentration-dose ratios in patientswho develop new onset diabetes mellitus after kidney transplantation. Transpl Int 2005; 18: 1152-1157
29. Boots JM, van Duijnhoven EM, Christiaans MH et al. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 2002; 13: 221-227